Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. [electronic resource]
- Seminars in cancer biology 02 2021
- 91-99 p. digital
Publication Type: Journal Article; Review
1096-3650
10.1016/j.semcancer.2019.08.016 doi
Animals Antineoplastic Agents--administration & dosage Carcinoma, Hepatocellular--drug therapy Drug Delivery Systems Humans Liver Neoplasms--drug therapy Nanomedicine Nanoparticles--administration & dosage